Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 827022-33-3 Chemical Structure| 827022-33-3

Structure of Palbociclib isethionate
CAS No.: 827022-33-3

Chemical Structure| 827022-33-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Palbociclib isethionate is a highly specific inhibitor of Cdk4 (IC50=11 nM) and Cdk6 (IC50=16 nM), having no activity against a panel of 36 additional protein kinases.

Synonyms: PD 0332991 isethionate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Palbociclib isethionate

CAS No. :827022-33-3
Formula : C26H35N7O6S
M.W : 573.66
SMILES Code : O=C1C(C(C)=O)=C(C)C2=CN=C(NC3=NC=C(N4CCNCC4)C=C3)N=C2N1C5CCCC5.OCCS(=O)(O)=O
Synonyms :
PD 0332991 isethionate
MDL No. :MFCD22666589
InChI Key :LYYVFHRFIJKPOV-UHFFFAOYSA-N
Pubchem ID :11478676

Safety of Palbociclib isethionate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P264-P270-P301+P310-P321-P330-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Palbociclib isethionate

Hedgehog

Isoform Comparison

Biological Activity

Target
  • CDK4

    CDK4/CyclinD3, IC50:9 nM

    CDK4/CyclinD1, IC50:11 nM

  • CDK6

    CDK6/CyclinD2, IC50:15 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
IB115 cells 1-4 μM 72 h Reduced Rb phosphorylation and induced apoptosis PMC5477309
MCF7 cells 500 nM 4 h Palbociclib competes with XO44 for CDK4 binding but not CDK2 PMC7592119
IB111 cells 1-4 μM 72 h Reduced Rb phosphorylation and induced apoptosis PMC5477309
HepG2 2.66 μM 72 h To evaluate the anti-proliferative activity of compound 11k, results showed significant inhibition on HepG2 cells PMC9012344
MCF7 cells 2 μM 30 min XO44 labels endogenous CDK4 and CDK2 to study ATP site occupancy PMC7592119
Huh7 and skHep1 cells 0.5 μM 14 days Palbociclib induced cellular senescence PMC5512174
HCT116 2.07 μM 72 h To evaluate the anti-proliferative activity of compound 11k, results showed significant inhibition on HCT116 cells PMC9012344
MDA-MB-468 1.34 μM 72 h To evaluate the anti-proliferative activity of compound 11k, results showed significant inhibition on MDA-MB-468 cells PMC9012344
H460 1.20 μM 72 h To evaluate the anti-proliferative activity of compound 11k, results showed significant inhibition on H460 cells PMC9012344
PC9 5 μM 48 h To evaluate the effect of GAA combined with CDK4/6 inhibitors, the results showed that GAA significantly reduced CDK6 expression and enhanced the sensitivity of CDK4/6 inhibitors PMC10349134
A549 5 μM 48 h To evaluate the effect of GAA combined with CDK4/6 inhibitors, the results showed that GAA significantly reduced CDK6 expression and enhanced the sensitivity of CDK4/6 inhibitors PMC10349134
Human liver cancer cell lines 1 μM 3 days Palbociclib suppressed cell proliferation by promoting a reversible cell cycle arrest PMC5512174

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice A549 cell subcutaneous tumor model Oral 100 mg/kg Once daily, 5 times/week To evaluate the anti-tumor effect of GAA combined with CDK4/6 inhibitors in vivo, the results showed that the combination treatment significantly inhibited tumor growth and prolonged the survival of mice PMC10349134
Mice Genetically engineered mouse model of liver cancer Oral 100 mg/kg Daily for 1 week Palbociclib significantly reduced tumour growth, either alone or in combination with sorafenib PMC5512174
Mice DDLPS xenograft model Oral gavage 130 mg/kg Five times per week for three weeks Evaluated the effect of Palbociclib alone on tumor growth, showing significant prolongation of progression-free survival PMC5477309

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.74mL

0.35mL

0.17mL

8.72mL

1.74mL

0.87mL

17.43mL

3.49mL

1.74mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories